Extracellular Vesicle-Based Therapeutics in Neurological Disorders

Neurological diseases remain some of the major causes of death and disability in the world. Few types of drugs and insufficient delivery across the blood–brain barrier limit the treatment of neurological disorders. The past two decades have seen the rapid development of extracellular vesicle-based t...

Descripción completa

Detalles Bibliográficos
Autores principales: Yuan, Yiwen, Sun, Jian, You, Tongyao, Shen, Weiwei, Xu, Wenqing, Dong, Qiang, Cui, Mei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9783774/
https://www.ncbi.nlm.nih.gov/pubmed/36559145
http://dx.doi.org/10.3390/pharmaceutics14122652

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9783774/
https://www.ncbi.nlm.nih.gov/pubmed/36559145
http://dx.doi.org/10.3390/pharmaceutics14122652

Ejemplares similares